Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.

Restylane Contour, a hyaluronic acid injectable dermal filler, has received FDA approval for the “correction of temple ...

Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing ...

Early calls, unexpected plans and moments you can’t plan are part of everyday living: and modern beauty should keep up. With ...

If the eyes are the window to the soul, the undereye area is the couch on which all of the soul's stresses like to lounge. Also called the tear trough, the undereye area can sometimes be a pretty good ...

Please provide your email address to receive an email when new articles are posted on . Restylane Eyelight is the first U.S. product formulated with non-animal stabilized hyaluronic acid technology ...

Although the Food and Drug Administration just approved the use of Restylane in December, the new injectable has already made its way to the Old Pueblo. Dr. Mikel Lo, a local cosmetic surgeon, has ...

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...

Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & Anti‑Aging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics ...